London, June 12, 2026, 13:01 BST
- Babcock International edged up in London trading. Delayed quotes showed buyers at 1,033.50p, a rise of 0.49%.
- Investors are watching for the FY26 full-year numbers out June 22. Focus will be on any details about the Type 31 frigate charge, cash flow, and what the company says about FY27 guidance.
- Analysts are still mostly positive. The target-price range is wide, showing execution risk is still a factor.
Babcock International Group PLC shares ticked up Friday as the market waited for the defence contractor’s full-year numbers. A late AJ Bell quote put the stock at a 1,032.50p sell and 1,033.50p buy, up 5.00p, or 0.49%. Market cap stands at about £5.05 billion. The P/E is 18.42. The price-to-earnings ratio compares share price with earnings per share and serves as a quick valuation check.
Babcock’s small move comes with the stock caught between the defence and nuclear story and ongoing worries about contract execution. In a post-close trading update, the company said it expects FY26 revenue at £5.27 billion before a roughly £100 million revenue reversal tied to the Type 31 programme. Underlying operating profit was £433 million excluding the Type 31 charge, or £293 million after. Operating margin stood at 8.2% before the charge and 5.7% after.
Babcock’s Type 31 frigate programme is still a concern for the bear case. The company flagged higher-than-expected rework, tied to design changes and earlier out-of-sequence build work, and now expects a £140 million charge. That will hit the books in FY26, with the cash outflow spread across the lifespan of the programme. This matters for shareholders, since defence contractors often land big, long-term contracts, but fixed-price or tricky engineering deals can squeeze margins if overruns pile up.
Cash flow, order book and buybacks are still the main bull arguments. Babcock posted £262 million in underlying free cash, cut net debt to £329 million, and ended the period with a £9.6 billion contract backlog. The board launched a new £200 million buyback after wrapping up the same amount in the last round. FY27 targets are unchanged, with roughly 70% of revenue already tied up in contracts as of April 1, 2026. The company stuck to its medium-term guide: mid-single-digit revenue growth, at least 9% operating margin and at least 80% cash conversion.
Babcock’s next key update lands June 22. The company plans to put out FY26 full-year numbers at 09:00 London time. Investors will look for details on the Type 31 provision, how far Babcock can go on its buyback without balance sheet stress, and if it can lift margins in Nuclear, Aviation and Land even as Marine takes the hit from the frigate.
Analysts lean positive, but risks remain. LSEG numbers shared by Investors Chronicle had five Buy ratings, three Outperform, one Hold, none at Sell or Strong Sell as of June 4. The median 12-month target sat at 1,400p, with the top at 1,675p and the low at 750p. That’s about 35% above the current quoted buy price at the median, but the low end points to real downside if things go wrong on execution or guidance.
Babcock is starting to look more attractive than just cheap, thanks to its defence exposure, improved balance sheet, ongoing buybacks, and bullish analyst calls. Valuation has support from these factors, but the main concern is the Type 31 charge, which could keep a lid on confidence in future margins. The share price barely moved on Friday, but investors are watching June 22 results instead: a clean audit, stable FY27 guidance, and clarity on contract risk could help the bull case. On the other hand, more pressure from Type 31 would leave the stock looking riskier even if target prices suggest upside.
